Market Estimates
Valuation Metrics
Financials
Trading Trends
RNA News & Events
Events Timeline

No data
News
People Also Watch
Frequently Asked Questions
What is Avidity Biosciences Inc (RNA) stock price today?
The current price of RNA is 72.37 USD — it has increased 0 % in the last trading day.
What is Avidity Biosciences Inc (RNA)'s business?
Avidity Biosciences, Inc. is a biopharmaceutical company. The Company is engaged in delivering a new class of ribonucleic acid (RNA) therapeutics called antibody oligonucleotide conjugates (AOCs). The AOCs are designed to combine the specificity of monoclonal antibodies with the precision of oligonucleotide therapies to address targets and diseases previously unreachable with existing RNA therapies. Its advancing and expanding pipeline has three programs in clinical development. The Del-desiran is designed to treat people with myotonic dystrophy type 1 (DM1) and is in the global Phase III HARBOR trial and in the ongoing MARINA-OLE trial in people with DM1. The Delpacibart braxlosiran is the first investigational therapy designed to directly target DUX4 in people living with facioscapulohumeral muscular dystrophy (FSHD). The Del-zota is designed for people with Duchenne muscular dystrophy (DMD) and is in development with the Phase II EXPLORE44 open-label extension (OLE) study.
What is the price predicton of RNA Stock?
Wall Street analysts forecast RNA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for RNA is 71.71 USD with a low forecast of 53.00 USD and a high forecast of 96.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
What is Avidity Biosciences Inc (RNA)'s revenue for the last quarter?
Avidity Biosciences Inc revenue for the last quarter amounts to 12.48M USD, increased 434.03 % YoY.
What is Avidity Biosciences Inc (RNA)'s earnings per share (EPS) for the last quarter?
Avidity Biosciences Inc. EPS for the last quarter amounts to -1.27 USD, increased 95.38 % YoY.
What changes have occurred in the market's expectations for Avidity Biosciences Inc (RNA)'s fundamentals?
How many employees does Avidity Biosciences Inc (RNA). have?
Avidity Biosciences Inc (RNA) has 391 emplpoyees as of January 09 2026.
What is Avidity Biosciences Inc (RNA) market cap?
Today RNA has the market capitalization of 10.91B USD.


![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fcover_image%2Fe504cad49caccd690e59612cdfc05484dc2d1cf3370edb4c971444650e279ed9.png&w=384&q=75)
![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fcover_image%2F142458dc9d75814c29767ddf4392620665b130bc5ec2d2f40513203a7e0284a8.png&w=384&q=75)
![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fcover_image%2Fb718869f62f92adf3af0e1c649afcf5e600648b063b50c627f115680626c3436.jpg&w=384&q=75)